CIT-Logo-White Created with Sketch.
News Issue Archive Device Guide Calendar Subscribe Advertising

MENU

Device Guides
Trial Guide
Centers

Coding CTO DES Hypertension Imaging Modalities PCI Pharmacology Radial Regulatory Structural Disease Valvular Interventions

News Current Issue Archive Device Guide Calendar Subscribe Advertising About Contact Privacy Submissions
Coding CTO DES Hypertension Imaging Modalities PCI Pharmacology Radial Regulatory Structural Disease Valvular Interventions

Advertisement

Advertisement

Search Results

Show Filters

close Created with Sketch.

Refine by Content Type

close Created with Sketch.

Refine by Year

close Created with Sketch.

Advertisement

Sort By:

Relevance Date

Choose Sites to Search:

CIToday CIToday + EVToday

cit | Article | 2025 Digital Exclusive No. 1

PE and Pregnancy: What’s Your Algorithm?

Considerations regarding diagnosis and management for pulmonary embolism in pregnant patients.

With Maya Serhal, MD, FACC, FSCAI, RPVI, and Sanjum S. Sethi, MD, MPH

cit | Article | January/February 2024

Atherectomy and Intravascular Lithotripsy for Calcium Modification

Pros, cons, and situations when one technology might be better than another.

By Kathleen Kearney, MD, and Taishi Hirai, MD

cit | Article | May/June 2011

Complications Associated With Transcatheter Therapy of Acute Vascular Thrombosis

A series of four children with congenital heart disease.

By Nazia Husain, MD, MPH, and Ralf J. Holzer, MD, MSC, FSCAI

cit | Article | July/August 2011

Novel Drug-Eluting Coronary Stents Nearing Approval in the United States

New stent platforms may offer enhanced performance, safety, and efficacy characteristics.

By Dean J. Kereiakes, MD, FACC

Advertisement

Advertisement

cit | News | May 19, 2009

CONFERENCE COVERAGE: EuroPCR

Edwards SOURCE Registry Presented for Sapien Valve May 20, 2009—At the EuroPCR conference in Barcelona, Spain, Edwards Lifesciences Corporation (Irvine, CA) announced the results from the SOURCE serial registry, its first postmarket study of consecutively enrolled Edwards Sapien transcatheter aortic valve patients.

cit | News | May 19, 2009

CONFERENCE COVERAGE: EuroPCR

Edwards SOURCE Registry Presented for Sapien Valve May 20, 2009—At the EuroPCR conference in Barcelona, Spain, Edwards Lifesciences Corporation (Irvine, CA) announced the results from the SOURCE serial registry, its first postmarket study of consecutively enrolled Edwards Sapien transcatheter aortic valve patients.

cit | News | May 12, 2023

Amarin’s Vascepa Studies Assess Coronary Physiology and Plaque Progression

May 12, 2023—Amarin Corporation plc announced new data describing the benefits of Vascepa/Vazkepa (icosapent ethyl) on coronary physiology and plaque progression.

cit | News | May 3, 2011

PCI Trends and Impact; Costs of New Devices Studied

May 4, 2011—In the Journal of the American Medical Association (JAMA), Andrew J. Epstein, PhD, Peter W. Groeneveld, MD, et al published a study of coronary revascularization trends in the United States from 2001 to 2008 (2011;305:1769–1776). On April 25, Drs. Epstein, Groeneveld, et al published research online ahead of print in the Archives of Internal Medicine that evaluated the impact of new cardiovascular device technology on health care cost.

cit | News | May 23, 2012

FDA Circulatory System Devices Panel Assesses Atrial Septal Defect Occluders

May 24, 2012—The US Food and Drug Administration's (FDA) Circulatory System Devices Panel met to discuss the current knowledge regarding the safety and effectiveness of the Amplatzer septal occluder (St.

cit | News | May 22, 2016

Pooled Analysis Supports Keystone Heart's TriGuard Cerebral Protection Device in TAVR Procedures

May 23, 2016—Keystone Heart, Ltd. announced the presentation of a pooled analysis of three prospective and comparable clinical studies of patients undergoing transcatheter aortic valve replacement (TAVR) in the United States and Europe.

cit | Article | July/August 2019

Large-Bore Access Site Management

State-of-the-art closure techniques for large-bore access.

By Amir Kaki, MD, and M. Chadi Alraies, MD

cit | Article | March/April 2012

Optical Imaging to Optimize Stent Evaluation and Outcomes

OCT offers a precise tool for vessel assessment to supplement coronary angiography.

By Giulio Guagliumi, MD, FESC, and Vasile Sirbu, MD

cit | Article | July/August 2024

Why Is There So Much Calcium, and Can We Prevent It?

Reviewing primary, secondary, and tertiary approaches to preventing the incidence, progression, and recurrence of atherosclerotic cardiovascular disease and related events.

By Aman Kansal, MD, and Jennifer Rymer, MD, MBA, MHS

cit | Article | March/April 2012

Multimodality Imaging for TAVR

Successful integration of multimodality imaging is essential for ensuring good outcomes as TAVR comes to the forefront of aortic stenosis treatment.

By Sachin S. Goel, MD; Paul Schoenhagen, MD; E. Murat Tuzcu, MD; and Samir R. Kapadia, MD

cit | Article | May/June 2021

Ventricular Reshaping Strategies in Heart Failure

Update on recent and ongoing clinical trials.

By Amit Alam, MD; Aasim Afzal, MD; and Susan M. Joseph, MD

cit | Article | 2025 Digital Exclusive No. 3

How to Build a Cardiogenic Shock Team

A practical guide for a team-based approach to improving cardiogenic shock outcomes.

By Vinoy S. Prasad, MD, FACC; Anthony Hilliard, MD, FACC; and Antoine Sakr, MD, FACC

cit | News | September 30, 2009

PCI for the Left Main Coronary Artery

With the availability of drug-eluting stents (DES) and the dramatic reduction in restenosis rates they have provided, the results of left main coronary artery (LMCA) stenting have certainly improved compared to preliminary experiences with bare-metal stents (BMS), which were limited by high restenosis rates and sudden deaths.1-6 Encouraging results have been reported at midterm clinical follow-up in some observational registries with elective DES implantation in the LMCA, with a 1-year mortality rate of 0% to 5%.7-12 In these registries, the need for target lesion revascularization (TLR) varied from 0% to 14%, and target vessel revascularization (TVR) varied from 0% to 19%.

cit | Article | May/June 2011

How Do OCT and IVUS Differ?

A comparison and assessment of these modern imaging modalities.

By Joshua Waggoner, MD, and Marc D. Feldman, MD, FACC, FSCAI

cit | Article | July/August 2021

From Neglected to Noticed: A Contemporary Understanding of Tricuspid Regurgitation Pathophysiology

Describing the anatomy and physiology of the tricuspid valve apparatus, including the annulus, leaflets, chordae tendineae, and papillary muscles among different types of tricuspid regurgitation.

By Yan Topilsky, MD, and Rebecca T. Hahn, MD, FACC

cit | Article | January/February 2023

Nonatherosclerotic Cardiovascular Diseases in Women

Reviewing the clinical presentation, pathophysiology, diagnostic pathway, and treatment of MINOCA, SCAD, and microvascular dysfunction in female patients.

By Ashwini Kerkar, MD; Stephane Manzo-Silberman, MD; Nadia R. Sutton, MD, MPH; and Shrilla Banerjee, MD, FRCP, FESC


1
2
3
4

Advertisement

Advertisement

Coding CTO DES Hypertension Imaging Modalities PCI Pharmacology Radial Regulatory Structural Disease Valvular Interventions
Centers

Coding CTO DES Hypertension Imaging Modalities PCI Pharmacology Radial Regulatory Structural Disease Valvular Interventions

News• Current Issue• Archive• Device Guides• Advertising• About Calendar• Contact• Privacy• Submissions• Subscriptions


Cardiac Interventions Today (ISSN 2572-5955 print and ISSN 2572-5963 online) is a publication dedicated to providing coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions.



magazine Created with Sketch.

Free Print Subscriptions

Fill 1 Created with Sketch.

Email Newsletter



twitter-icon LinkedIn Created with Sketch. BlueSky-Circle
Endovascular Today
CIT-Logo-Color Created with Sketch.
bmc-secondary-mark-color copy Created with Sketch.

© 2026 Bryn Mawr Communications II, LLC.  
All Rights Reserved   •   Privacy Policy

one-trust-button